| Is there any association between Hashimoto’s thyroiditis and thyroid cancer? A retrospective data analysis DM Alcântara-Jones, TF Alcântara-Nunes, BO Rocha, RD Oliveira, ... Radiologia brasileira 48, 148-153, 2015 | 27 | 2015 |
| Interferon-alpha (IFN) therapy discontinuation is feasible in myeloproliferative neoplasm (MPN) patients with complete hematological remission RD De Oliveira, J Soret-Dulphy, LP Zhao, C Marcault, N Gauthier, ... Blood 136, 35-36, 2020 | 21 | 2020 |
| Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms MA Porto-Soares, RD Oliveira, GM Cortopassi, JA Machado-Neto, ... Hematology, transfusion and cell therapy 42, 238-244, 2020 | 12 | 2020 |
| SF3B1 mutations in the driver clone increase the risk of evolution to myelofibrosis in patients with myeloproliferative neoplasms (MPN) LP Zhao, RD De Oliveira, C Marcault, J Soret, N Gauthier, E Verger, ... Blood 136, 1, 2020 | 8 | 2020 |
| Co‐occurrence of BCR–ABL1‐positive chronic myeloid leukaemia and CALR‐mutated essential thrombocythaemia VEF da Costa, RD de Oliveira, F Traina, F Chahud, LC Palma, ... British Journal of Haematology 188 (3), e21-e23, 2020 | 6 | 2020 |
| Myeloproliferative Neoplasms (MPN) clonal evolution landscape and its impact on patients' prognosis LP Zhao, M Cazaux, N Maslah, RD De Oliveira, E Verger, J Soret-Dulphy, ... Blood 138, 317, 2021 | 4 | 2021 |
| Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19 Z Ghrieb, S Allaoua, J Huang, N Langner, F François, C Maréchal, ... Therapies 76 (4), 347-358, 2021 | 2 | 2021 |
| Ruxolitinib treatment is associated with increased incidence of infections and higher risk of HSV/VZV recurrence in patients with myeloproliferative neoplasm (MPN) related … N Gauthier, J Soret-Dulphy, LP Zhao, RD De Oliveira, C Marcault, ... Blood 136, 8, 2020 | 2 | 2020 |
| NFE2 mutations impact AML transformation and overall survival in patients with myeloproliferative neoplasms (MPN) C Marcault, LP Zhao, RD De Oliveira, J Soret, N Gauthier, E Verger, ... Blood 136, 36, 2020 | 2 | 2020 |
| Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2. 0 over MYSEC-PM M Guerra, H Pasquer, RD de Oliveira, J Soret-Dulphy, N Maslah, LP Zhao, ... American journal of hematology, 2024 | 1 | 2024 |
| Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID) D Elessa, LP Zhao, RD de Oliveira, N Maslah, J Soret-Dulphy, E Verger, ... Leukemia 37 (8), 1741-1744, 2023 | 1 | 2023 |
| Genomic Landscape and Clinical Features of Myeloproliferative Neoplasm (MPN) Patients with Auto-Immune and Inflammatory Diseases (AID) D Elessa, LP Zhao, RD De Oliveira, N Maslah, J Soret-Dulphy, E Verger, ... Blood 138, 1496, 2021 | 1 | 2021 |
| Chronic exposure to cytoreductive treatment shapes clonal evolution in myeloproliferative neoplasms LP Zhao, N Maslah, RD De Oliveira, E Verger, J Soret-Dulphy, C Marcault, ... Blood 138, 3620, 2021 | 1 | 2021 |
| Involvement of the JAK‐STAT pathway in the molecular landscape of tyrosine kinase fusion‐negative hypereosinophilic syndromes: A nationwide CEREO study M Groh, L Fenwarth, M Labro, A Boudry, E Fournier, M Wemeau, ... American Journal of Hematology, 2024 | | 2024 |
| CALR‐mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM L Aubin, R Vilas Boas, R Daltro De Oliveira, V Le Brun, M Divoux, J Rey, ... American Journal of Hematology, 2024 | | 2024 |
| Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia M Groh, L Fenwarth, A Boudry, E Fournier, A Marceau-Renaut, J Abraham, ... Blood 142, 78, 2023 | | 2023 |
| Caractéristiques phénotypiques et mutationnelles des maladies auto-immunes et inflammatoires (MAI) associées aux néoplasies myéloprolifératives (NMP) D Elessa, LP Zhao, RD De Oliveira, N Maslah, J Soret-Dulphy, E Verger, ... La Revue de Médecine Interne 42, A299-A300, 2021 | | 2021 |
| Co‐occurrence of BCR–ABL1‐positive chronic myeloid leukaemia and CALR‐mutated essential thrombocythaemia. VEF Costa, RD Oliveira, F Traina, F Chahud, LC Palma, ... British Journal of Haematology 188 (3), 2020 | | 2020 |
| Derrame pericárdico e tamponamento cardíaco após o uso de bortezomibe para tratamento de mieloma múltiplo GM Cortopassi, LT Silva, RD Oliveira, PMM Garibaldi, VEF Costa, ... Revista Brasileira de Hematologia e Hemoterapia 39, S183-S184, 2017 | | 2017 |
